These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23641689)

  • 1. Insights into antibody-drug conjugates: bioanalysis and biomeasures in discovery.
    Clark T; Han X; King L; Barletta F
    Bioanalysis; 2013 May; 5(9):985-7. PubMed ID: 23641689
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioanalysis special focus issue on antibody-drug conjugates.
    Kaur S
    Bioanalysis; 2013 May; 5(9):981-3. PubMed ID: 23641688
    [No Abstract]   [Full Text] [Related]  

  • 3. Key bioanalytical measurements for antibody-drug conjugate development: PK/PD modelers' perspective.
    Shah DK; Barletta F; Betts A; Hansel S
    Bioanalysis; 2013 May; 5(9):989-92. PubMed ID: 23641690
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioanalytical methods for therapeutic monoclonal antibodies and antibody-drug conjugates: A review of recent advances and future perspectives.
    Todoroki K; Mizuno H; Sugiyama E; Toyo'oka T
    J Pharm Biomed Anal; 2020 Feb; 179():112991. PubMed ID: 31761377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paper.
    Gorovits B; Alley SC; Bilic S; Booth B; Kaur S; Oldfield P; Purushothama S; Rao C; Shord S; Siguenza P
    Bioanalysis; 2013 May; 5(9):997-1006. PubMed ID: 23641692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Antibody-Drug Conjugates by Mass Spectrometry.
    Jayathirtha M; Darie CC
    Adv Exp Med Biol; 2019; 1140():251-263. PubMed ID: 31347052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy.
    St Denis TG; Hamblin MR
    Bioanalysis; 2013 May; 5(9):1099-114. PubMed ID: 23641699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PK assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine.
    Dere R; Yi JH; Lei C; Saad OM; Huang C; Li Y; Baudys J; Kaur S
    Bioanalysis; 2013 May; 5(9):1025-40. PubMed ID: 23641694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Mass Spectrometric Tools for the Bioanalyses of Therapeutic Monoclonal Antibodies and Antibody-Drug Conjugates.
    Todoroki K; Yamada T; Mizuno H; Toyo'oka T
    Anal Sci; 2018; 34(4):397-406. PubMed ID: 29643301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALDI-MS: a Rapid and Reliable Method for Drug-to-Antibody Ratio Determination of Antibody-Drug Conjugates.
    Abedi M; Ahangari Cohan R; Mahboudi F; Shafiee Ardestani M; Davami F
    Iran Biomed J; 2019 Nov; 23(6):395-403. PubMed ID: 31104399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reversed-phase high-performance liquid chromatography method for analysis of monoclonal antibody-maytansinoid immunoconjugates.
    Fleming MS; Zhang W; Lambert JM; Amphlett G
    Anal Biochem; 2005 May; 340(2):272-8. PubMed ID: 15840500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catabolism of antibody drug conjugates and characterization methods.
    Shadid M; Bowlin S; Bolleddula J
    Bioorg Med Chem; 2017 Jun; 25(12):2933-2945. PubMed ID: 28438386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates.
    Li Y; Gu C; Gruenhagen J; Yehl P; Chetwyn NP; Medley CD
    MAbs; 2016; 8(4):698-705. PubMed ID: 26891281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatography-high-resolution mass spectrometry for regulated bioanalysis: bile acid and oligonucleotide quantitation as a reference.
    Meng M
    Bioanalysis; 2016 Dec; 8(24):2519-2521. PubMed ID: 27884073
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies to address drug interaction potential for antibody-drug conjugates in clinical development.
    Lu D; Sahasranaman S; Zhang Y; Girish S
    Bioanalysis; 2013 May; 5(9):1115-30. PubMed ID: 23641700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-drug conjugates nonclinical support: from early to late nonclinical bioanalysis using ligand-binding assays.
    Kumar S; King LE; Clark TH; Gorovits B
    Bioanalysis; 2015; 7(13):1605-17. PubMed ID: 26226310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody Subunit LC-MS Analysis for Pharmacokinetic and Biotransformation Determination from In-Life Studies for Complex Biotherapeutics.
    Kellie JF; Pannullo KE; Li Y; Fraley K; Mayer A; Sychterz CJ; Szapacs ME; Karlinsey MZ
    Anal Chem; 2020 Jun; 92(12):8268-8277. PubMed ID: 32392410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the composition of immunoconjugates using size-exclusion chromatography coupled to mass spectrometry.
    Lazar AC; Wang L; Blättler WA; Amphlett G; Lambert JM; Zhang W
    Rapid Commun Mass Spectrom; 2005; 19(13):1806-14. PubMed ID: 15945030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the drug-to-antibody ratio distribution for antibody-drug conjugates in plasma/serum.
    Xu K; Liu L; Dere R; Mai E; Erickson R; Hendricks A; Lin K; Junutula JR; Kaur S
    Bioanalysis; 2013 May; 5(9):1057-71. PubMed ID: 23641696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioanalysis of antibody-drug conjugates.
    Gorovits B
    Bioanalysis; 2015; 7(13):1559-60. PubMed ID: 26226305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.